NFKB1 and cancer: Of the 72 patients, 63 cancer tissues (87.5%) and 57 pericarcinoma tissues (79.2%) expressed NF-κB p65 mRNA (RI, 0.412±0.266; and 0.281±0.231, respectively; t=2.969, P=0.004).